Improved Mitochondrial Function Peptides such as MOTS-C support metabolic balance and energy efficiency, which can benefit tired, inflamed, or aging skin
Food and Drug Administration have reported increased numbers of Emergency Room Visits and hospitalizations related to complications caused by GLP-1 medications
Through dedicated protein and peptide engineering efforts, we managed to create the first ever oral biologic of its kind - oral semaglutide for type 2 diabetes launched in 2019
Studies show that higher protein intake (1.21.6 grams per kilogram of body weight daily) prevents muscle loss while on GLP-1 therapy, maintaining your metabolism as weight decreases
Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation
Current research status Retatrutide is currently in Phase 3 clinical trials, with Eli Lilly conducting multiple large-scale studies